IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Regeneron Pharmaceuticals

CUSIP: 75886F907 | 36 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Bdf-Gestion3,335
0.3% of portfolio›$2.5M
StyleTurnoverLocationFiled
Bdf-Gestion
3,335$2.5M0.3%GrowthMediumParis, India2026-10-19